STARDEV Study: Neurodevelopmental Trajectory and Long‐Term Outcomes of Patients with Startle Disease/Hyperekplexia
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Diane Pina und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Hôpital Femme-Mère-Enfant, Lyon, France. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Hyperekplexia, Stiff-Person Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Although initial clinical presentation of hyperekplexia/startle disease is well known, data regarding long‐term clinical outcomes is lacking.
Objectives
We provide a long‐term evaluation from clinical and pharmacological perspectives, focusing on neurodevelopmental trajectory.
Methods
Twenty‐eight patients from nine French hospitals were included based on clinical diagnosis criteria. Adaptive abilities were assessed using VABS‐II.
Results
VABS‐II showed preserved adaptive abilities, except in motor skills. Early development was marked by neurodevelopmental delay in 53% of patients, with 57% developing neurodevelopmental disorders, primarily specific learning disorders. Intellectual disability and/or autism spectrum disorder were present in five patients. Symptoms were most frequent during the first 3 years of life, with persistence of exaggerated startle reflex and falls. One‐quarter of the patients discontinued clonazepam. A genetic variant was found in 85% of patients, involving one of the three main genes GLRA1 , SLC6A5 , or GLRB .
Conclusions
Our findings highlight preserved adaptive abilities, frequent neurodevelopmental disorders and long‐term pharmacodependence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Neurology, Hôpital Femme-Mère-Enfant, Lyon, France.
- Department of Pediatric Neurology, CHU Montpellier, INM, INSERM U1298, Montpellier, France.
- Department of Pediatric Neurology, Hôpital de Hautepierre, Strasbourg, France.
- AP-HP. Sorbonne Université, Service de Neuropédiatrie et Centre de Référence Neurogénétique, Hôpital Armand Trousseau, Paris, France.
- Department of Pediatric Neurology, Hôpital Necker-Enfants Malades, Paris, France.
- Clinical Investigation Center, Hôpital Louis Pradel, Lyon, France.
ORCID-Profile: Diane Pina, Regis Lopez
Zitieren
APA
Pina, D., Roubertie, A., Spitz, M. A., Ravelli, C., Bahi-Buisson, N., Gheurbi, F., Buchy, M., Loppinet, T., Chemaly-Perin, N., Nougues, M. C., Heron, B., Lopez, R., Anheim, M., Fradin, M., Cances, C., Avez-Couturier, J., Dalmon, F., Lesca, G., Des Portes, V., & Lion-François, L. (2025). STARDEV Study: Neurodevelopmental Trajectory and Long‐Term Outcomes of Patients with Startle Disease/Hyperekplexia. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70071
Vancouver
Pina D, Roubertie A, Spitz MA, Ravelli C, Bahi-Buisson N, Gheurbi F, et al. STARDEV Study: Neurodevelopmental Trajectory and Long‐Term Outcomes of Patients with Startle Disease/Hyperekplexia. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70071
BibTeX
@article{Pina2025,
author = {Pina, Diane and Roubertie, Agathe and Spitz, Marie-Aude and Ravelli, Claudia and Bahi-Buisson, Nadia and Gheurbi, Farha and Buchy, Marion and Loppinet, Thomas and Chemaly-Perin, Nicole and Nougues, Marie-Christine and Heron, Benedicte and Lopez, Regis and Anheim, Mathieu and Fradin, Mélanie and Cances, Claude and Avez-Couturier, Justine and Dalmon, Fabienne and Lesca, Gaëtan and Des Portes, Vincent and Lion-François, Laurence},
title = {STARDEV Study: Neurodevelopmental Trajectory and Long‐Term Outcomes of Patients with Startle Disease/Hyperekplexia},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.70071}
}
EUVIMED